Blog
RSS FeedPosted by Michael Wonder on 10 Feb 2021
Due to aducanumab’s new PDUFA date, ICER extends timeline for Alzheimer’s disease assessment
10 February 2021 - The ICER announced today it has extended its timeline for assessing the comparative clinical effectiveness and ...
Posted by Michael Wonder on 08 Jul 2020
ICER reschedules cystic fibrosis public meeting for 27 August 2020
8 July 2020 - Registration is now open. ...
Posted by Michael Wonder on 18 Mar 2020
ICER indefinitely postpones public meetings for sickle cell disease and cystic fibrosis; expands other assessment timelines up to three months
18 March 2020 - Updated schedules are intended to enable participating clinical experts and patient advocates to focus on caring for ...
Posted by Michael Wonder on 17 Sep 2016
ICER announces updates to timeline for review of therapies for multiple sclerosis
16 September 2016 - The ICER has updated the timeline of its review of disease-modifying therapies for patients with multiple sclerosis. ...